Effects of Galvus (Vildagliptin) on interleukin-6 in Diabetic Foot Ulcer
Phase of Trial: Phase IV
Latest Information Update: 10 Sep 2018
At a glance
- Drugs Vildagliptin (Primary) ; Metformin
- Indications Diabetes mellitus
- Focus Therapeutic Use
- Acronyms GIED
- 03 Sep 2018 Planned End Date changed from 30 Apr 2016 to 30 Jul 2022.
- 19 Mar 2015 Status changed from not yet recruiting to recruiting, according to the Australian New Zealand Clinical Trials Registry record.
- 28 May 2013 New trial record